Jing Chen
Jing Chen publishes mostly in Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology, on topics such as Intracerebral and Subarachnoid Hemorrhage Research, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
- World rank
- #1,675,140 of 7,710,434 ranked researchers
- Rank in China
- #253,223 of 978,568
- Works
- 384
- Citations
- 6.3k
- Citations per work
- 16.3
What does Jing Chen research?
Jing Chen's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else20753.9%
- Health Sciences15139.2%
- Medicine15139.2%
- Life Sciences266.9%
- 1Pulmonary and Respiratory Medicine11% of their works
- 2Endocrinology, Diabetes and Metabolism8% of their works
- 3Epidemiology8% of their works
- 4Neurology7% of their works
- 5Molecular Biology7% of their works
- 6Surgery6% of their works
Research topics
Which keywords describe Jing Chen's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Immunotherapy, Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage, ALK Inhibitors, EGFR Mutations and Brain Metastases.
- Disease
- Autophagy
- Thyroid Dysfunction
- Ischemic Stroke
- Radiosurgery
- Brain Metastases
- ALK Inhibitors
- Cerebral Amyloid Angiopathy
- Targeted Therapy
- Clinical Trials
- Immunotherapy
- Intracerebral Hemorrhage
- EGFR Mutations
- Genomic Profiles
- Small-Cell Lung Cancer
- Thrombolysis
- Thyroid Hormone
- Cushing's Syndrome
- Pituitary Adenomas
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Clinical Trials312 topics
- Targeted Therapy312 topics
- Immunotherapy282 topics
- Cerebral Amyloid Angiopathy211 topic
- Intracerebral Hemorrhage211 topic
- ALK Inhibitors171 topic
- EGFR Mutations171 topic
- Brain Metastases141 topic
- Genomic Profiles141 topic
- Radiosurgery141 topic
- Small-Cell Lung Cancer141 topic
- Ischemic Stroke131 topic
- Thrombolysis131 topic
- Thyroid Dysfunction121 topic
- Thyroid Hormone121 topic
- Autophagy111 topic
- Cushing's Syndrome111 topic
- Disease111 topic
- Pituitary Adenomas111 topic
Where does Jing Chen work?
Jing Chen's main affiliation in the publication record is Sichuan University, China.
How many publications and citations does Jing Chen have?
OpenAlex counts 384 works and 6,260 citations for Jing Chen, an h-index of 34, ranking #1,675,140 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Jing Chen
- jing-chen-chinese-academy-of-sciences-china-3
- jing-chen-chinese-academy-of-sciences
- jing-chen-university-of-cincinnati-medical-center
- jing-chen-nankai-university
- jing-chen-tulane-university
- jing-chen-boston-childrens-hospital-united-states
- jing-chen-southeast-university
- jing-chen-chinese-academy-of-sciences-china
- jing-chen-nanjing-university-of-posts-and-telecommunications
- jing-chen-huazhong-university-of-science-and-technology-china
- jing-chen-peking-university-china-3
- jing-chen-peking-university
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jing Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.